PNI Institute (PNII) finalized the formulation of a novel, clinically proven, non-invasive, out-patient post-acute and chronic pain treatment system, seen as a "paradigm shift" in the singularly fastest growing sector in medicine- pain management. The driving core component, going forward, is a ‘seed' methodology patent #8,428,738- Coupled Neuraxial Mesoscopic Desynchronization Electrostimulation Therapy (cNMDET) Method issued recently, 23 April 2013. Projections support recurrent annual revenues in excess of $684M in the 6th year of operation. Operationally, throughout US strategically placed ‘central facilities’ will be implemented to provide the appropriate level of redundancy for the reliable delivery via the internet, services, data storage and retrieval sufficiently to support services to each service subscriber throughout the US, whether individual physician, institution, etc. Technology Readiness Level (TRL) 8/9. Please use link below to DOE/TVC 'POSTER' presented 04/13.